12
Pipeline Molecules
Under Investigation
Pipeline & Clinical Trials
Pipeline at a Glance
Sumitomo Pharma America, Inc. is advancing a portfolio of investigational therapies across multiple areas, including central nervous system (CNS) and oncology. Our research and development efforts focus on targeted small molecules and emerging modalities designed to address areas of unmet medical need.
- 12
Active Clinical Trials
Across Various Phases
- 8
Recruiting Participants
Open for Enrollment
Filters:
No results match the selected filters.
Expanded Access Program
Sumitomo Pharma America, Inc. may consider access to investigational products outside of clinical trials for eligible patients who have no alternative treatment options.
View Expanded Access ProgramContact Us
Medical Science Liaisons
Find and connect with your Medical Affairs Contact, also known as Medical Science Liaison (MSL), in your region and specialty.
Sign Up for Updates
Stay informed and stay current with updates delivered directly to your inbox.
Medical Information
Submit a request for more information.
+ 1 (800) 739-0565Monday - Friday, 8 AM - 8 PM ET
Report an Adverse Event or Product Complaint
Please report any side effects related to any Sumitomo Pharma America, Inc. medication by contacting us. You may also contact the US Food and Drug Administration (FDA) directly by visiting www.fda.gov/Safety/MedWatch or calling 1-800-FDA-1088.